NCT05949177 Graded Exposure and Mindfulness Meditation for Patients Post-ACL Reconstruction
| NCT ID | NCT05949177 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of North Carolina, Chapel Hill |
| Condition | Anterior Cruciate Ligament Injuries |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2024-10-30 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2024-10-30 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To evaluate the effect of graded exposure and mindfulness meditation after ACLR, the investigators will determine the effect of graded exposure and mindfulness meditation to 1) decrease self-reported injury-related fear and reinjury anxiety, and 2) improve lower extremity reaction time when compared to a waitlist control group.
Eligibility Criteria
Inclusion Criteria: * Ages 14-35 years * Have self-reported levels of fear on the Tampa Scale of Kinesiophobia-11 and the Photographic Series of Sports Activities for ACLR * Injured their knee playing or training for sports (recreational or organized) * Have a history of unilateral ACLR * 6 months to 10-years post-ACLR Exclusion Criteria: * History of secondary ACL injury * Do not exhibit elevated injury-related fear * Concomitant surgeries at the time of ACL reconstruction
Contact & Investigator
Shelby E Baez, Ph.D., ATC
PRINCIPAL INVESTIGATOR
UNC-Chapel Hill
Frequently Asked Questions
Who can join the NCT05949177 clinical trial?
This trial is open to participants of all sexes, aged 14 Years or older, up to 35 Years, studying Anterior Cruciate Ligament Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05949177 currently recruiting?
Yes, NCT05949177 is actively recruiting participants. Contact the research team at sbaez@unc.edu for enrollment information.
Where is the NCT05949177 trial being conducted?
This trial is being conducted at Chapel Hill, United States.
Who is sponsoring the NCT05949177 clinical trial?
NCT05949177 is sponsored by University of North Carolina, Chapel Hill. The principal investigator is Shelby E Baez, Ph.D., ATC at UNC-Chapel Hill. The trial plans to enroll 50 participants.